VEGFA and neoplasm: The efficient disruption of various integrin-mediated interactions formed between tumorigenic ECMs and angiogenic EC in tumoral microenvironments seems to be critical from the therapeutic standpoint since, as recently reported [60], one important downside of pharmacologic VEGF/PDGF blockade is the persistence of basement membranes from involuted tumor vessels after both EC and pericytes undergo regression.